卡波西瘤在脏移植接受者:一个案例报告在帕克利塔克塞尔的反应
Hiba Ghabi1, Marwa Trabelsi1, Alia Zheni2
1Nephrology, Dialysis and Kidney Transplantation Department, Rabta Hospital, Tunis, Tunisia.
Case reports in oncology
|March 9, 2026
概括
在移植患者中,早期发病的卡波西肉瘤 (KS) 可以成功治疗. 这一案例突出了帕克利塔塞尔化疗与西洛利木斯结合的有效第一线治疗,用于移植后的KS.
科学领域:
- 在瘤学瘤学.
- 移植医学 移植医学
- 皮肤病学 皮肤病学
背景情况:
- 移植后的免疫抑制疗法增加了卡波西肉瘤 (KS) 的风险.
- 移植后的KS发作是可变的,通常在2年内.
- 对于移植后的KS,全身疗法的有效性尚未得到充分证实.
研究的目的:
- 报告一个罕见的早期发病的卡波西肉瘤 (KS) 病例,该病例发生在移植接受者身上.
- 评估帕克利塔塞尔作为移植后癌症的第一线治疗方法的有效性.
主要方法:
- 一名52岁的男性脏移植接受者在移植后6个月出现了深静脉血栓和皮肤病变.
- 卡波西肉瘤 (KS) 的诊断通过皮肤活检得到证实.
- 治疗包括帕克利塔塞尔化学疗法,西洛利木斯和降低免疫抑制.
主要成果:
- 患者显示显著的临床改善与KS病变解决.
- 在治疗期间,功能保持稳定.
- 到2024年11月,观察到显著的临床改善.
结论:
- 移植患者的早期KS是一种罕见但严重的并发症.
- 基于帕克利塔塞尔的化学疗法与西洛利木斯和调整的免疫抑制显示出作为一线治疗的前景.
- 这种方法为移植后卡波西肉瘤的管理提供了一个潜在的有效策略.
相关概念视频
Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Kidney Transplant II: Surgical Procedure
926
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
926
Kidney Transplant III: Nursing Management
631
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
631


